Effect of Lipo-prostaglandin E1on Mesangial Proliferative Glomerulonephritis in Rats
- Author:
Changqing LUO
1
;
Xiaoli ZHANG
;
Yumei WANG
;
Zhonghua ZHU
;
Anguo DENG
Author Information
1. Union Hospital,Tongji Medical College,Huazhong University of Science and Technology
- Keywords:
prostaglandins E1;
nephritis;
extracellular matrix
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2005;25(5):516-518
- CountryChina
- Language:Chinese
-
Abstract:
The antinephritic effect of lipo-prostaglandin E1, prostaglandin E1 incorporated in lipid microspheres was investigated using an experimental model of mesangial proliferative glomerulonephritis (MsPGN). Twenty-two female rats were randomly divided into nephritic group (N, n= 6),lipo-prostaglandin E1 treated group (NL, n = 8) and control group (C, n = 6). Lipo-prostaglandin E1 was given intravenously at 40 μg · kg-1 · d-1 from the 6th week to the 8th week. Twenty-four h urinary protein contents and blood creatinine (Cr) were determined and the pathological changes were observed in the experiment. The expression of proliferating cell nuclear antigen (PCNA), extracellular matrix (fibronectin, FN; collagen type Ⅳ, Col Ⅳ) and transforming growth factor β1(TGFβ1) was detected by using immunohistochemistry. The results showed that lipo-prostaglandin E1 significantly inhibited the glomerular histopathological changes as well as the elevation of plasma Cr (P＜0.05). The overexpression of PCNA, FN, Col Ⅳ and TGFβ1 were also obviously inhibited in group NL as compared with the group N (P＜0.01). It was suggested that lipo-prostaglandin E1could improve renal function, inhibit the proliferation of glomerular cells and reduce the deposition of extracellular matrix, which may be related to the down-regulation of the TGFβ1 expression.
